|
Real-time Estimate
Cboe BZX
18:52:35 18/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 17.04 USD | -1.81% |
|
+25.74% | -0.44% |
| 08-14 | Omeros Corporation Announces Appointment of Joseph Schocken as Director and Audit Committee Member, Effective August 12, 2026 | CI |
| 08-13 | Omeros Swings to Q2 Adjusted Earnings; Shares up | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.26B | - | - | - | - | |
| 73.25B | |||||
| 61.95B | |||||
| 28.02B | - | ||||
| 24.15B | |||||
| 23.01B | - |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
